Horizons in World Cardiovascular Research. Volume 2.
- 1st ed.
- 1 online resource (319 pages)
- Horizons in World Cardiovascular Research ; v.2 .
- Horizons in World Cardiovascular Research .
Intro -- HORIZONS IN WORLD CARDIOVASCULAR RESEARCH VOLUME 2 -- HORIZONS IN WORLD CARDIOVASCULAR RESEARCH VOLUME 2 -- CONTENTS -- PREFACE -- Chapter 1 BENEFICIAL CLINICAL EFFECTS OF PERHEXILINE IN CARDIAC PATIENTS: MULTIPLE BIOCHEMICAL MECHANISMS -- ABSTRACT -- CLINICAL APPLICATIONS OF PERHEXILINE -- Stable and Unstable Angina Pectoris -- Aortic Stenosis -- Heart Failure -- PHARMACOKINETICS AND TOXICITY OF PERHEXILINE -- PHARMACOLOGY OF PERHEXILINE -- Hemodynamics -- Ion Channels -- Metabolic Shift -- Interactions with NO Signaling Pathway -- NO resistance in cardiovascular disease states -- Mechanisms of NO resistance -- Amelioration of platelet NO resistance by perhexiline -- Oxidative Stress and Inflammation -- CONCLUSION AND FUTURE PERSPECTIVES -- REFERENCES -- Chapter 2 DRUG-INDUCED VALVULAR HEART DISEASE -- ABSTRACT -- 1. INTRODUCTION -- 2. PATHOPHYSIOLOGY OF DRUG-INDUCED VALVULAR HEART DISEASE -- 2.1. Serotonin Metabolism -- 2.2. The Serotonin Transporter (SERT) -- 2.3. Role of the 5-HT2B Receptor in Drug-Induced Valvular Heart Disease -- 3. MORPHOLOGICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS -- 3.1. Histopathological Features -- 3.2. Echocardiographical Characteristics -- 4. DRUGS ASSOCIATED WITH VALVULAR HEART DISEASE -- 4.1. Ergotamine and Methysergide -- 4.2. Fenfluramine/Phentermine and Dexfenfluramine -- 4.3. Pergolide and Cabergoline -- 4.4. Bromocriptine -- 4.5. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") -- 4.6. Other Drugs -- 5. INFLUENCE OF DRUG DOSE, TREATMENT DURATION AND RISK FACTORS -- 6. NATURAL COURSE OF TOXIC VALVULOPATHY -- 7. SMALL ANIMAL MODELS OF DRUG-INDUCED VALVULAR HEART DISEASE -- 8. PRACTICAL RECOMMENDATIONS FOR THE USE OF POTENTIAL VALVULOPATHIC DRUGS -- ABBREVIATIONS -- REFERENCES -- Chapter 3 SHARED SUSCEPTIBILITY GENES OF METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE -- ABSTRACT -- INTRODUCTION. The Renin Angiotensin System -- Trigylecrid Metabolism Affecting Genetic Variants -- Genetic Factors in Glucose Homeostasis -- Mutations Involved in Inflammatory Pathways -- Other Contributing Genetic Factors -- CONCLUDING REMARKS -- REFERENCES -- Chapter 4 CARDIAC PACING: A REVIEW CHAPTER -- ABSTRACT -- INTRODUCTION -- ELECTRICAL CONDUCTION -- Blood Pressure -- Cardiac Output -- Stroke Volume -- CLINICAL CARDIAC PACING INDICATIONS -- Atrioventricular (AV) Block -- Sinus Node Abnormalities -- INTRAVENTRICULAR CONDUCTION -- Cardiac Pacing Therapies -- Transcutaneous Pacing -- Temporary Transvenous Pacing -- Permanent Transvenous Pacing -- OVERVIEW OF PACEMAKERS -- Single Chamber Pacing Operation -- TRANSESOPHAGEAL PACING AND MECHANICAL CARDIAC PACING -- Transesophageal Pacing -- Mechanical Cardiac Pacing -- Pharmacological Remedies -- FOLLOW-UP -- SUMMARY -- REFERENCES -- Chapter 5 RHEUMATIC VALVULOPATHY: CURRENT UNDERSTANDING OF PATHOGENESIS AND PERSPECTIVE OF IMMUNOBIOLOGICAL TREATMENTS -- ABSTRACT -- INTRODUCTION -- EPIDEMIOLOGY AND ETIOLOGIC AGENT -- Genetic Susceptibility and Pathogenesis -- DIAGNOSIS AND CLINICAL MANIFESTATIONS -- Carditis -- Arthritis -- Erythema Marginatum -- Subcutaneous Nodules -- Chorea -- Other Manifestations -- LABORATORY INVESTIGATION -- Evidence of a Recent Streptococcal Infection -- Inflammatory Markers -- Synovial Fluid Analysis -- DIFFERENTIAL DIAGNOSIS -- TREATMENT -- Treatment of the Clinical Manifestations -- Surgical treatment -- Prophylaxis -- Vaccine -- FUTURE PERSPECTIVES -- REFERENCES -- Chapter 6 CARDIAC PACING AND COGNITION: A REVIEW OF CURRENT EVIDENCE -- ABSTRACT -- Background -- Objectives -- Methods -- Results -- Conclusion -- INTRODUCTION -- SEARCH STRATEGY AND SELECTION CRITERIA -- I. COGNITIVE IMPAIRMENT AND CARDIAC FACTORS -- Vascular dementia (VaD) -- Vascular Cognitive Impairment (VID). Cardiovascular factors in Alzheimer's disease -- Atrial Fibrillation and Cognitive Impairment -- Heart Failure and Cognitive Impairment -- Coronary Artery Disease and Cognitive Impairment -- II. CARDIAC PASSING AND REVERSIBILITY OF COGNITION -- III. ACETYLCHOLINESTERASE INHIBITORS AND CARDIAC PACING -- CONCLUSION -- REFERENCES -- Chapter 7 ORAL BACTERIA DETECTED IN THE HEARTS OF PATIENTS WITH VALVULAR DISEASES -- ABSTRACT -- 1. INTRODUCTION -- 2. ORAL DISEASES AND BACTEREMIA -- 3. INFECTIVE ENDOCARDITIS INDUCED BY ORAL BACTERIA -- 4. DETECTION OF ORAL BACTERIA IN HEART VALVE -- 1. Dental Caries -- 2. Periodontal Diseases -- 5. FUTURE PERSPECTIVE -- 6. CONCLUSION -- REFERENCES -- Chapter 8 CHRONIC PERSISTENT INFECTIONS AS A RISK FACTOR FOR ISCHEMIC HEART DISEASE: THE HELICOBACTER PYLORI MODEL -- ABSTRACT -- INTRODUCTION -- PERSISTENT INFECTION AND IHD -- POSTULATED CAUSATIVE MECHANISMS FOR INFECTION-INDUCED IHD -- Dyslipidemia -- Homocysteinemia -- Changes in pro- and Atherogenic Proinflammatory Cytokines -- Oxidative Stress -- Induction of Hypercoagulability -- Metabolic Dysregulation -- Direct Impact on Atheromas -- Molecular Mimicry -- Miscelaneous Effects -- THE ROLE OF HOST'S PREDISPOSITION -- COEXISTENCE OF CHRONIC PERSISTENT INFECTIONS-THE UBIQUITOUS PATHOGEN "BURDEN" AND THE MULTIPLE HITS THEORY -- CONCLUSION-ANTIMICROBIAL THERAPY FOR IHD? -- REFERENCES -- Chapter 9 BICUSPID AORTIC VALVE IN ATHLETES -- BICUSPID AORTIC VALVE IN ATHLETES: SIMILARITIES AND DIFFERENCES WITH GENERAL POPULATION -- History -- Embriology and Morphology of BAV -- Genetic -- BAV and Associated Congenital Cardiovascular Lesions -- Clinical Symptoms -- Echocardiographyc Exam -- Echocardiographyc Evaluation of the Aortic Tract in BAV -- Left Ventricle Chamber in BAV Athletes -- Management of BAV Athletes by Physical Echo Stress Exam. The Complementary Information by Speckle Tracking Analysis on LV Performance -- Magnetic Resonance Imaging (MRI) -- The Natural History of BAV in General Population and in Athletes -- Surgical Treatment of BAV -- Final Considerations on Behalf of Our Experiences -- REFERENCES -- Chapter 10 SHARED TRIGLYCERIDE METABOLISM-ASSOCIATED SUSCEPTIBILITY GENES OF ISCHEMIC STROKE AND CORONARY ARTERY DISEASE -- ABSTRACT -- GENOME WIDE ASSOCIATION STUDIES -- Atherosclerosis -- Triglyceride Metabolism -- Ischemic Stroke -- Coronary Artery Disease -- Shared Alleles of Triglyceride Metabolism -- CONCLUDING REMARKS -- REFERENCES -- Chapter 11 SOME NEW APPROACHES TO HEART RATE VARIABILITY ANALYSIS -- Methods -- Results -- Conclusions -- 1. DYNAMICS OF THE STATES OF HEART RATE REGULATION DURING 24-H MONITORING -- Methods -- Results and Discussion -- Conclusions -- 2. CONTINUOUS WAVELET ANALYSIS: A NEW METHOD FOR STUDYING NONSTATIONARY OSCILLATIONS IN THE CARDIAC RHYTHM -- Conclusions -- REFERENCES -- Chapter 12 ALTERATIONS IN CELL CYCLE AND FETAL GENE RE-EXPRESSION IN ISCHEMIC HEART DISEASE -- ABSTRACT -- INTRODUCTION -- FETAL GENE REACTIVATION AND CELL CYCLE REACTIVATION -- Oxidative Stress and Apoptosis -- Vasculogenesis and Angiogenesis -- Therapeutic Possibilities -- CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- Chapter 13 NUMERICAL SIMULATION OF HEMODYNAMIC IN THE PATIENT-SPECIFIC AORTA AFTER AORTIC VALVE REPLACEMENT BASED ON MRI-DATA -- ABSTRACT -- 1. INTRODUCTION -- 2. MATERIAL AND METHOD -- 2.1. Acquisition -- 2.2. Segmentation -- 2.3. Conversion -- 2.4. Simulation Model -- 2.4.1. Individual Geometry -- 2.4.2. Meshing -- 2.4.3. Boundary conditions -- 3. RESULTS -- 3.1. Domain "Valve" -- 3.2. Domain "Bulbus" -- 3.3. Domain "Outs" -- 3.4. Domain "Aorta" -- 3.5. Verification -- 4. CONCLUSION -- REFERENCES. Chapter 14 PREDICTION OF CARDIAC MORTALITY AND EVENTS BY MYOCARDIAL PERFUSION IMAGING: DIFFERENCES BETWEEN JAPANESE AND AMERICAN POPULATIONS -- ABSTRACT -- INTRODUCTION -- UNDERLYING FACTORS OF CORONARY ARTERY DISEASE -- NUCLEAR IMAGING AND PROGNOSTIC STUDIES -- Nuclear Imaging to Detect Myocardial Ischemia -- Prognostic Evaluation for Adverse Cardiac Events -- J-ACCESS Japanese Prognostic Study -- CHARACTERISTICS OF CARDIAC EVENTS IN JAPAN -- FUTURE DIRECTIONS -- CONCLUSION -- ACKNOWLEDGEMENT -- REFERENCES -- Chapter 15 ATRIAL NATRIURETIC PEPTIDE: IS ANP ASSOCIATED WITH RESTENOSIS AFTER CORONARY ARTERY STENTING? -- ABSTRACT -- INTRODUCTION -- MATERIALS AND METHODS -- Subjects -- Genotyping -- Statistical Analysis -- RESULTS -- DISCUSSION -- REFERENCES -- INDEX -- Blank Page.
9781616686390
Cardiovascular system -- Diseases. Cardiovascular system -- Diseases -- Research.